LI
ARNA

LMCG Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History

LMCG Investments’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,200
Closed -$50K – 546
2014
Q3 		$50K Buy
+1,200
New +$53.6K ﹤0.01% 466

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LMCG Investments's ARNA Position: Q4 2014 in Review

LMCG Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2014, closing a stake of 1,200 shares — an estimated $50K sold.

LMCG Investments first reported a position in ARNA in Q3 2014 and held it in 1 quarter. The position peaked at $50K in Q3 2014. 129 funds tracked by Wall St. Rank hold ARNA as of Q4 2014.

  • LMCG Investments reported no remaining Arena Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • LMCG Investments sold 1,200 Arena Pharmaceuticals Inc shares in Q4 2014, an estimated $50K.
  • LMCG Investments first reported a position in Arena Pharmaceuticals Inc in Q3 2014 and held it in 1 quarter.
  • LMCG Investments's Arena Pharmaceuticals Inc position peaked at $50K in Q3 2014.
  • 129 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2014.

Based on LMCG Investments's 13F filing for Q4 2014, filed 13 Feb 2015.